Ganeden’s GanedenBC30 (Bacillus coagulans GBI-30, 6086) has received FDA generally recognized as safe (GRAS) certification for infant formulas, on top of previous certifications that covered products that could be fed to infants and children.
An independent and critical evaluation was performed reviewing the safety of GanedenBC30 relating to usage in infant formulas.
The evaluation was conducted by a panel of safety experts, including the Chair of the Department of Pediatrics at Massachusetts General Hospital and Harvard Professor, and overseen by AIBMR. Scientific research on Ganeden’s strain was evaluated.
The panel determined that GanedenBC30 is GRAS for use in infant formula.
Probiotics have become increasingly popular in infant products as awareness continues to rise around the importance of boosting beneficial bacteria from the start of life.
Babies are born with sterile digestive tracts, and a variety of factors can affect the natural gut flora and the development of their digestive system.
“Whether a baby is bottle fed, delivered via C-section or has to be put on antibiotics all adversely affect their gastrointestinal system,” said David Keller, VP of scientific operations.
“It is important to build up the good bacteria, and using a proven probiotic strain like GanedenBC30 can aid infants in this process.”
GanedenBC30 was the first Bacillus strain to receive GRAS directly from the FDA for adult usage, and has already been formulated into more than 550 probiotic foods and beverages worldwide, including children’s products.
